BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15078250)

  • 1. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
    Minor PD
    Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for the development of pre-mortem laboratory diagnostic tests for Creutzfeldt-Jakob disease.
    Dabaghian RH; Mortimer PP; Clewley JP
    Rev Med Virol; 2004; 14(6):345-61. PubMed ID: 15495196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
    Zhang W; Wu J; Li Y; Carke RC; Wong T
    Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
    Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
    Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.
    Sowemimo-Coker SO; Demczyk CA; Andrade F; Baker CA
    Transfusion; 2010 May; 50(5):980-8. PubMed ID: 20003057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays.
    Cooper JK; Ladhani K; Minor PD
    Vox Sang; 2007 May; 92(4):302-10. PubMed ID: 17456154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
    Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
    PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of infectivity in variant Creutzfeldt-Jakob disease.
    Sivakumaran M
    Lancet; 2002 Mar; 359(9308):801. PubMed ID: 11888628
    [No Abstract]   [Full Text] [Related]  

  • 11. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urinary PrPSc as a diagnostic test for sporadic, variant, and familial CJD.
    Head MW; Kouverianou E; Taylor L; Green A; Knight R
    Neurology; 2005 May; 64(10):1794-6. PubMed ID: 15911815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
    Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
    Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 16. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant Creutzfeldt-Jakob disease and blood transfusion.
    Turner ML
    Curr Opin Hematol; 2001 Nov; 8(6):372-9. PubMed ID: 11604578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mad cow disease: towards a blood screening test].
    Nau JY
    Rev Med Suisse; 2005 Sep; 1(31):2058. PubMed ID: 16212011
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue safety in view of CJD and variant CJD.
    Pauli G
    Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.